Stability and bioequivalence challenges in generic drug formulation: A regulatory perspective
Crossref DOI link: https://doi.org/10.30574/gscbps.2025.31.2.0189
Published Online: 2025-05-30
Update policy: https://doi.org/10.30574/gscbps.ourcrossmarkpolicy
Maria Elise DuPont,